The BTK Inhibitor CC-292 shows activity in Mantle Cell Lymphoma and synergizes with Lenalidomide and NIK Inhibitors depending on NFκB mutational status
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Mantle Cell lymphoma (MCL) were treated with the BTK inhibitor 1mM CC-292 for 48h We used microarrays to uncover the mechanisms underlying CC-292 activity in Mantle Cell lymphoma (MCL) Global RNA expression was done in two MCL cell lines treated in vitro with CC-292 for 48h
创建时间：
2019-03-21
